Gujarat FDCA approves licences of 189 hand sanitisers to meet growing demand amidst COVID-19 pandemic

The Gujarat FDCA has approved product licences of 189 hand sanitisers to tide over its growing demand due to the pandemic. The product licenses are mostly from small and medium Indian manufacturers which are complying with the provisions of cosmetic rules.

Adequate supply of sanitisers and antiretroviral (ARV) drugs like chloroquine phosphate has been maintained in the wake of pandemic.

According to an official associated with the development, “A state level committee has also been formed to oversee the consistent supply of ARV drugs, masks and sanitisers.”

The committee is headed by Gujarat Food and Drug Control Administration (FDCA) Commissioner Dr HG Koshia with members from the state industry department and state pollution control board.

Dr Koshia informed that, “This has to be followed religiously as the Central Government has notified Essential Commodities (EC) Order, 2020 to regulate the production, quality, distribution, logistics of masks (2ply and 3ply surgical masks, N95 masks) and hand sanitizers for COVID-19 management. We have made the provision of approving licenses for sanitisers production and distribution under the emergency use authorization for consistent supply.”
The EC order notification shall remain in force for a period up to June 30, 2020 from the date of its publication in the official gazette.

  • Related Posts

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’